CN111175389A - Method for detecting zhongshengmycin F by high performance liquid chromatography - Google Patents

Method for detecting zhongshengmycin F by high performance liquid chromatography Download PDF

Info

Publication number
CN111175389A
CN111175389A CN201911156453.2A CN201911156453A CN111175389A CN 111175389 A CN111175389 A CN 111175389A CN 201911156453 A CN201911156453 A CN 201911156453A CN 111175389 A CN111175389 A CN 111175389A
Authority
CN
China
Prior art keywords
zhongshengmycin
phase
sample
high performance
performance liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911156453.2A
Other languages
Chinese (zh)
Inventor
张楠
潘忠成
杨宏勃
高波
陈豪
李蒲民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Microbe Biotechnology Co ltd
Original Assignee
Shaanxi Microbe Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Microbe Biotechnology Co ltd filed Critical Shaanxi Microbe Biotechnology Co ltd
Priority to CN201911156453.2A priority Critical patent/CN111175389A/en
Publication of CN111175389A publication Critical patent/CN111175389A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8679Target compound analysis, i.e. whereby a limited number of peaks is analysed

Landscapes

  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Library & Information Science (AREA)
  • Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a method for detecting zhongshengmycin F by high performance liquid chromatography, which adopts the following chromatographic conditions: a chromatographic column: taking alkylsilane bonded silica embedded with polar groups as a stationary phase; mobile phase: organic phase-aqueous phase; the flow rate is 0.5-1.5ml/min, and the detection wavelength is 190-210 nm; column temperature: 10-40 ℃; sample introduction amount: 5-20 muL; the detector adopts an ultraviolet detector or a diode array detector. The existing method adopts a bioassay method for quantification, and a method of pre-column derivation is used as a qualitative method, the chromatographic column and the mobile phase are matched for use, so that the good separation degree and accuracy are obtained, the zhongshengmycin F and the homologue with a similar structure are well separated by the detection method, and the detection accuracy of the zhongshengmycin F is improved; in the detection method, the probiotins F peak time is about 8.8 min.

Description

Method for detecting zhongshengmycin F by high performance liquid chromatography
Technical Field
The invention belongs to the technical field of pesticide detection and analysis, and particularly relates to a method for detecting zhongshengmycin F by high performance liquid chromatography.
Background
Zhongshengmycin, the chemical name of which is streptothricins, is one of the earliest discovered antibiotics, among which streptothricins F was discovered as early as 1942 by the Waksman research group, but its chemical structure was not finalized by artificial total synthesis until 1982, in which the structural formula of the F component is as follows:
Figure 246418DEST_PATH_IMAGE001
the chemical structure of zhongshengmycin is composed of three parts of streptadine lactam, gulosamine and lysine side chain, 7 main components with bactericidal activity are provided, the lysine quantity is named as streptothricin F, E, D, C, B, A and X from 1 to 7 respectively, the activity is integrally related with the lysine quantity, namely the activity is stronger when the lysine quantity is larger.
The zhongshengmycin has wide antibacterial spectrum, can resist gram-positive bacteria, gram-negative bacteria, mycobacteria, saccharomycetes and filamentous fungi, and has moderate toxicity to human and livestock. The currently and effectively registered zhongshengmycin raw medicines and preparations in China have 41 varieties, wherein 1 of 12 percent of zhongshengmycin raw medicine registered products and the other 40 of the zhongshengmycin raw medicines are wettable powder, granules, aqueous solutions and the like, and the mixed preparation occupies a large proportion and is mainly used for preventing and treating diseases such as apple ring spot, cucumber bacterial angular leaf spot, tomato bacterial wilt and the like.
The quality standard of the pesticide product is the technical basis for the production, inspection and quality assessment of the product, and the scientific and effective quality standard of the product is the technical guarantee for ensuring the stable prevention and treatment effect of the pesticide. Compared with the chemical synthetic pesticide, the agricultural antibiotic has the characteristics of low raw medicine content, complex components and the like, and has greater difficulty in developing a detection method. From the current published data, the existing effective zhongshengmycin products have 6 product quality standards which are enterprise standards, namely Q/KLSW013-2018 < 12% zhongshengmycin mother medicine > of FujiaKaili biological products limited company, Q/KLSW 033-2018 < 3% zhongshengmycin soluble agent >, Q/KLSW 030-2018 < 0.5% zhongshengmycin granule >, Q/XNDZ124-2016 < 3% zhongshengmycin wettable powder > of Fujian New agriculture and Zhengzhengzhengshengmycin limited company, Q/370202HYJ 373-2018 < 2.0% zhongshengmycin aqua > of Heliang pharmaceutical products limited company, Q/73023813-3.7-2017% zhongshengmycin aqua agent of Sichuan Jinzhu ecological agriculture science limited company, and the control indexes of zhongshengmycin in the 6 enterprise standards are biological potency respectively.
Biological potency as a control index is very common in early agricultural and medical antibiotic quality standards, but the biological potency method has great limitations, such as long analysis time, poor reproducibility among laboratories, many human interference factors, and the like. Even more fatal is that many mixed preparations of zhongshengmycin are available, and the mixing of two bactericidal active compounds, especially the mixing of two bactericidal active compounds with a bactericide with antibacterial activity has a great problem in terms of theory that the content of zhongshengmycin measured by a biological potency method is inaccurate and is not feasible.
The chromatography has the advantages of short analysis time, good result reproducibility, accurate quantification of specific compounds and the like, and the trend of replacing the biological titer method with the chromatography has become the quality standard of antibiotics in recent years. In the above industry standards, liquid chromatography pre-column derivatization is used as a method for identifying the zhongshengmycin, but obvious defects exist in the technical details of the method. One is that the OPA pre-column derived product is not specific, and the first peak in the standard is selected for quantification, which has great randomness, because the proportion of the product is not fixed, the reaction result of the same sample also has great difference, the pre-column derived requirement is that the reaction is carried out quantitatively, and the product is specific; secondly, fluorescence detection is adopted, but in the method, only the detection wavelength is given to be 360nm, and the fluorescence detection must have two key parameters of the excitation wavelength and the detection wavelength. Since identification methods must be listed as required in the quality standards of pesticide products, the listing of the methods may be primarily in a form that meets the quality standards of the products of the enterprise and is not practically feasible.
Zhongshengmycin F is similar to its homologues in structure and is susceptible to interference from some of the homologues in HPLC detection. There is therefore a great need in the art for a method for detecting zhongshengmycin F with good separation and short run-time.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a method for detecting zhongshengmycin F by using a high performance liquid chromatography, which can realize the separation of the zhongshengmycin F from other homologues, thereby achieving the control of the product quality.
The invention adopts the following technical scheme that a method for detecting zhongshengmycin F by high performance liquid chromatography adopts the following chromatographic conditions;
a chromatographic column: taking alkylsilane bonded silica gel of an embedded polar group as a stationary phase;
mobile phase: organic phase-aqueous phase;
flow rate: 0.5-1.5mL/min, preferably 1.0 mL/min;
detection wavelength: 190-210nm, preferably 200 nm;
column temperature: 10-40 ℃, preferably 30 ℃;
sample introduction amount: 5-20 muL, preferably 10 muL;
a detector: an ultraviolet detector or a diode array detector.
In a preferred embodiment of the present invention, the chromatographic column using the embedded polar group-containing alkylsilane bonded silica as the stationary phase is preferably a chromatographic column using the embedded polar group-containing octadecylsilane bonded silica as the stationary phase.
In a preferred embodiment of the present invention, the organic phase in the mobile phase is selected from one or more of methanol and acetonitrile.
In a preferred embodiment of the invention, the aqueous phase of the mobile phase further contains sodium heptanesulfonate at a concentration by mass ranging from 0.05% to 0.15%, preferably 0.1%.
In a preferred embodiment of the invention, the aqueous phase of the mobile phase also contains phosphoric acid, the concentration by mass of phosphoric acid being in the range 0.1% to 0.3%, preferably 0.1%.
In a preferred embodiment of the invention, the mobile phase has a volume ratio of organic phase to aqueous phase of from 0:100 to 30:70, preferably 20: 80.
In a preferred embodiment of the invention, the column is used in conjunction with a flow.
The method for detecting zhongshengmycin F by the high performance liquid chromatography is realized by the following steps:
(1) weighing a standard containing a proper amount of zhongshengmycin F, dissolving the standard in a 50mL volumetric flask by using pure water, fixing the volume, shaking up uniformly, and filtering a 0.45 mu m filter membrane for preparing a test standard solution;
(2) weighing a sample containing a proper amount of zhongshengmycin F, dissolving the sample in a 50mL volumetric flask by using pure water, performing constant volume and shaking up, and filtering a 0.45 mu m filter membrane for preparing a sample to be tested;
(3) and (3) injecting the sample to be tested and the sample solution to be tested into a high performance liquid chromatograph, and performing high performance liquid chromatography analysis according to the chromatographic conditions.
In a preferred embodiment of the invention, the purity of the standard is higher than 99.9%.
The existing method adopts a bioassay method for quantification, and a method of pre-column derivation is used as a qualitative method, compared with the prior art, the method has the advantages that the chromatographic column and the mobile phase are matched for use, so that the good separation degree and accuracy are obtained, the zhongshengmycin F and the homologue with the similar structure are well separated by the detection method, and the detection accuracy and the detection efficiency of the zhongshengmycin F are greatly improved; in the detection method, the probiotins F peak time is about 8.8 min.
Drawings
The invention is further described below with reference to the accompanying drawings:
FIG. 1 is a high performance liquid chromatogram of a Zhongshengmycin F sample isolated according to the conditions of example 1;
FIG. 2 is a high performance liquid chromatogram of a Zhongshengmycin F sample isolated according to the conditions of example 2;
FIG. 3 is a high performance liquid chromatogram of a Zhongshengmycin F sample isolated according to the conditions of example 3;
FIG. 4 is a linear relationship diagram of the analysis method of the present invention.
Detailed Description
The present invention will be described in further detail with reference to examples, but the present invention is not limited to only the following examples.
Example 1
Experimental apparatus and conditions:
waters1525 high performance liquid chromatograph, Waters2489 ultraviolet detector;
a chromatographic column: c18 (150X 4.6mm, 5 μm) of an embedded polar group;
mobile phase: (0.1% sodium heptanesulfonate +0.1% phosphoric acid) aqueous solution: acetonitrile =80: 20;
flow rate: 1.0 mL/min;
detection wavelength: 200 nm;
column temperature: 30 ℃;
sample introduction amount: 10 muL.
The test steps are as follows:
weighing a standard containing 0.02g of zhongshengmycin F, dissolving the standard in a 50mL volumetric flask by using pure water, fixing the volume, shaking up uniformly, and filtering a filter membrane of 0.45 mu m for preparing a test standard solution;
weighing a sample containing 0.02g of zhongshengmycin F, dissolving the sample in a 50mL volumetric flask by using pure water, fixing the volume, shaking up, and filtering a filter membrane of 0.45 mu m for preparing a sample to be tested;
and (3) injecting the test sample and the sample solution to be tested into a high performance liquid chromatograph, performing high performance liquid chromatography analysis according to the chromatographic conditions, and recording a chromatogram. The results are shown in FIG. 1, and the peak-off time of the main peak of Zhongshengmycin F is 8.8min as shown in FIG. 1.
Example 2
Experimental apparatus and conditions:
waters1525 high performance liquid chromatograph, Waters2489 ultraviolet detector;
a chromatographic column: c18 (150X 4.6mm, 5 μm) of an embedded polar group;
mobile phase: (0.1% sodium heptanesulfonate +0.1% phosphoric acid) aqueous solution: acetonitrile =80: 20;
flow rate: 1.0 mL/min;
detection wavelength: 205 nm;
column temperature: 30 ℃;
sample introduction amount: 10 muL.
The test steps are as follows:
weighing a standard containing 0.02g of zhongshengmycin F, dissolving the standard in a 50mL volumetric flask by using pure water, fixing the volume, shaking up uniformly, and filtering a filter membrane of 0.45 mu m for preparing a test standard solution;
weighing a sample containing 0.02g of zhongshengmycin F, dissolving the sample in a 50mL volumetric flask by using pure water, fixing the volume, shaking up, and filtering a filter membrane of 0.45 mu m for preparing a sample to be tested;
and (3) injecting the test sample and the sample solution to be tested into a high performance liquid chromatograph, performing high performance liquid chromatography analysis according to the chromatographic conditions, and recording a chromatogram. The results are shown in FIG. 2, where the time to peak of the Zhongshengmycin F main peak is 8.8min, as shown in FIG. 2.
Example 3
Experimental apparatus and conditions:
waters1525 high performance liquid chromatograph, Waters2489 ultraviolet detector;
a chromatographic column: c18 (150X 4.6mm, 5 μm) of an embedded polar group;
mobile phase: (0.15% sodium heptanesulfonate +0.1% phosphoric acid) aqueous solution: acetonitrile =80: 20;
flow rate: 1.0 ml/min;
detection wavelength: 200 nm;
column temperature: 30 ℃;
sample introduction amount: 10 muL.
The test steps are as follows:
weighing a standard containing 0.02g of zhongshengmycin F, dissolving the standard in a 50mL volumetric flask by using pure water, fixing the volume, shaking up uniformly, and filtering a filter membrane of 0.45 mu m for preparing a test standard solution;
weighing a sample containing 0.02g of zhongshengmycin F, dissolving the sample in a 50mL volumetric flask by using pure water, fixing the volume, shaking up, and filtering a filter membrane of 0.45 mu m for preparing a sample to be tested;
and (3) injecting the test sample and the sample solution to be tested into a high performance liquid chromatograph, performing high performance liquid chromatography analysis according to the chromatographic conditions, and recording a chromatogram. The results are shown in FIG. 3, where the time to peak of the Zhongshengmycin F main peak is 8.8min, as shown in FIG. 3.
Linear correlation test of analytical methods
Weighing about 0.1g of Zhongshengmycin standard substance and a 50ml volumetric flask, dissolving with ultrapure water, fixing the volume, respectively transferring 1, 5, 8, 10 and 15 into 5 50ml volumetric flasks, dissolving and fixing the volume, and preparing Zhongshengmycin standard solution as shown in the table below. After the instrument is stable, sampling is carried out according to the concentration from low to high. And taking the mass concentration of the zhongshengmycin as a horizontal coordinate and the peak area as a vertical coordinate to prepare a standard curve.
The standard curve was measured as shown in table 1 below: y =10986x +302421, and the linear correlation coefficient is R2= 0.9995. The zhongshengmycin has good linear relation in the concentration range of 47.7 mu g/mL-715.8 mu g/mL. The linear relationship is shown in fig. 4.
TABLE 1 results of linear correlation experiments for analytical methods
Figure 967118DEST_PATH_IMAGE002
Accuracy test of analytical methods
Weighing 5 samples from a Zhongshengmycin F sample with known mass fraction, respectively adding a certain amount of Zhongshengmycin standard sample, and analyzing according to the detection method of the invention, wherein the average recovery rate of Zhongshengmycin F is 99.45% as shown in Table 2.
TABLE 2 accuracy test results of analytical methods
Figure 162607DEST_PATH_IMAGE003
Precision test of analytical methods
5 samples are accurately weighed from the same sample and analyzed according to the detection method of the invention, as shown in Table 3, the relative standard deviation of the zhongshengmycin F is 0.74 percent after being parallelly detected for 5 times under the detection method, and is less than the calculated value 1.139 of Horwitz equation 2 (1-0.5 logC) multiplied by 0.67, and the precision under the method is proved to meet the method confirmation requirement.
TABLE 3 precision test results of analytical methods
Figure 326872DEST_PATH_IMAGE004
Sensitivity test of analytical methods
The sample A1 was diluted in a gradient (2-fold, 4-fold, 8-fold, 16-fold … …) and was gradually diluted until no active ingredient was detected. As shown in table 4, the data indicates: the minimum detection limit of the zhongshengmycin is about 3ppm, can meet the detection of common constants, and is suitable for the detection of a zhongshengmycin mother medicine and related preparation products.
TABLE 4 sensitivity test results of the analytical methods
Figure 289537DEST_PATH_IMAGE005
The test results show that the detection method has higher accuracy and precision, good linear relation and wide sensitivity application range.
Compared with the existing liquid chromatography conditions, the liquid chromatography conditions of the invention have better separation degree for zhongshengmycin F, thereby ensuring the detection accuracy. The invention fills the blank of high performance liquid detection and quantification of zhongshengmycin, and simultaneously solves the defects of nonspecific pre-column derivative products, long analysis time of a bioassay method, poor reproducibility among laboratories and the like.
The above preferred embodiments are only for illustrating the patent content of the present invention, and other embodiments of the present invention are also possible, but those skilled in the art should be able to adopt the technical teaching of the present invention and equivalent alternatives or equivalent modifications and fall within the protection scope of the present invention.

Claims (10)

1. A method for detecting zhongshengmycin F by high performance liquid chromatography is characterized by adopting the following chromatographic conditions:
a chromatographic column: taking alkylsilane bonded silica gel of an embedded polar group as a stationary phase;
mobile phase: organic phase-aqueous phase;
flow rate: 0.5-1.5 ml/min;
detection wavelength: 190-210 nm;
column temperature: 10-40 ℃;
sample introduction amount: 5-20 muL;
a detector: an ultraviolet detector or a diode array detector.
2. The method according to claim 1, characterized in that the following chromatographic conditions are used: flow rate: 1.0 ml/min; detection wavelength: 200 nm; column temperature: 30 ℃; sample introduction amount: 10 muL.
3. The method according to claim 2, wherein the chromatographic column using the embedded polar group-containing alkylsilane bonded silica as the stationary phase and the chromatographic column using the embedded polar group-containing octadecylsilane bonded silica as the stationary phase.
4. The method according to any one of claim 3, wherein the organic phase in the mobile phase is selected from one or more of methanol and acetonitrile.
5. A process according to any one of claims 3, characterized in that the aqueous phase of the mobile phase also contains sodium heptanesulfonate, the mass concentration of sodium heptanesulfonate being in the range 0.05% -0.15%, preferably 0.1%.
6. The method according to any one of claims 3, characterized in that the aqueous phase of the mobile phase also contains phosphoric acid, the concentration by mass of phosphoric acid being in the range 0.1% to 0.3%, preferably 0.1%.
7. The process according to claim 3, wherein the mobile phase has an organic phase-aqueous phase volume ratio of from 0:100 to 30:70, preferably 20: 80.
8. A method according to claim 3, wherein the chromatographic column is used in conjunction with a flow.
9. The method according to any one of claims 1-8, characterized by the following steps:
(1) weighing a standard containing a proper amount of zhongshengmycin F, dissolving the standard in a 50mL volumetric flask by using pure water, fixing the volume, shaking up uniformly, and filtering a 0.45 mu m filter membrane for preparing a test standard solution;
(2) weighing a sample containing a proper amount of zhongshengmycin F, dissolving the sample in a 50mL volumetric flask by using pure water, performing constant volume and shaking up, and filtering a 0.45 mu m filter membrane for preparing a sample to be tested;
(3) and (3) injecting the sample to be tested and the sample solution to be tested into a high performance liquid chromatograph, and performing high performance liquid chromatography analysis according to the chromatographic conditions.
10. The method of claim 9, wherein said standard is greater than 99.9% pure.
CN201911156453.2A 2019-11-22 2019-11-22 Method for detecting zhongshengmycin F by high performance liquid chromatography Pending CN111175389A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911156453.2A CN111175389A (en) 2019-11-22 2019-11-22 Method for detecting zhongshengmycin F by high performance liquid chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911156453.2A CN111175389A (en) 2019-11-22 2019-11-22 Method for detecting zhongshengmycin F by high performance liquid chromatography

Publications (1)

Publication Number Publication Date
CN111175389A true CN111175389A (en) 2020-05-19

Family

ID=70657137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911156453.2A Pending CN111175389A (en) 2019-11-22 2019-11-22 Method for detecting zhongshengmycin F by high performance liquid chromatography

Country Status (1)

Country Link
CN (1) CN111175389A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896753A (en) * 2021-11-16 2022-01-07 陕西麦可罗生物科技有限公司 Method for efficiently separating zhongshengmycin from fermentation liquor
CN114276392A (en) * 2021-12-28 2022-04-05 陕西麦可罗生物科技有限公司 Zhongshengmycin F component mother medicine and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103901128A (en) * 2014-03-27 2014-07-02 深圳诺普信农化股份有限公司 Analysis method of Zhongshengmycin content
US20170304288A1 (en) * 2013-11-20 2017-10-26 Texas Southern University Formulations of Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170304288A1 (en) * 2013-11-20 2017-10-26 Texas Southern University Formulations of Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases
CN103901128A (en) * 2014-03-27 2014-07-02 深圳诺普信农化股份有限公司 Analysis method of Zhongshengmycin content

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAYTE MARTÍNEZ-MARTÍNEZA ET AL.: "Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin", 《EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896753A (en) * 2021-11-16 2022-01-07 陕西麦可罗生物科技有限公司 Method for efficiently separating zhongshengmycin from fermentation liquor
CN114276392A (en) * 2021-12-28 2022-04-05 陕西麦可罗生物科技有限公司 Zhongshengmycin F component mother medicine and preparation method thereof

Similar Documents

Publication Publication Date Title
Mackenzie et al. Ethyl carbamate formation in grain based spirits: part ii the identification and determination of cyanide related species involved in ethyl carbamate formation in scotch grain whisky
CN111175389A (en) Method for detecting zhongshengmycin F by high performance liquid chromatography
CN112461960B (en) Method for simultaneously measuring various heterocyclic pesticides, degradation products and intermediates in water
CN111579658B (en) Content analysis method of indoxacarb chiral intermediate
Hladik et al. Methods of analysis-Determination of pesticides in sediment using gas chromatography/mass spectrometry
Zhang et al. Sensitive determination of melamine leached from tableware by reversed phase high-performance liquid chromatography using 10-methyl-acridone-2-sulfonyl chloride as a pre-column fluorescent labeling reagent
CN111308002A (en) Method for detecting isoxazoline insecticide and impurities thereof
Wimmer et al. Analysis of diflubenzuron by gas chromatography/mass spectrometry using deuterated diflubenzuron as internal standard
CN101216468B (en) 2-methoxymethyl-4-aminophenol and its impurity highly effective liquid phase chromatography analytical method
CN108802215A (en) The assay method of Rynaxypyr residual quantity in a kind of vegetables
CN107991408B (en) Method for measuring content of index component in four-flavor Zhenzhi eye drops
CN113607836B (en) Analysis method for content of indoxacarb key intermediate
CN112345663B (en) Analysis method for content of 5-chloro-2-methoxycarbonyl-1-indanone ester
CN103175906B (en) Qualitative and quantitative detection method for each component of validamycin
CN111208215A (en) Method for detecting impurity 2-mercaptobenzothiazole in ceftriaxone sodium
CN111855873B (en) Method for determining triazine herbicide residue in aquatic product by ultra-high performance liquid chromatography-tandem mass spectrometry
CN110596269B (en) Content determination method for simultaneously detecting multiple components in creatine powder
CN114740125A (en) LC-MS-based 10 cardiovascular drug serum detection method and kit
CN114487247A (en) Glufosinate-ammonium and metabolite determination kit, and preparation method and determination method thereof
CN108828101B (en) Method for determining diuron residues in sugarcane based on 3, 4-dichloroaniline
Chi et al. Enantiomeric resolution, stereochemical assignment and toxicity evaluation of TPA enantiomers
CN112763622A (en) Method for determining plamavir through liquid chromatography
CN111812237A (en) Valproic acid drug concentration detection kit and application thereof
CN115184527B (en) Detection method of heliotropin impurity
CN110646540B (en) HPLC-ELSD detection method for Retamolin starting material and intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200519

RJ01 Rejection of invention patent application after publication